Regulatory Compliance & Quality Systems – Page 6

Stability data gaps during WHO PQ assessment – CAPA expectations for PQ approval

Identifying early warning signs of stability data issues is crucial to preventing downstream problems during a WHO PQ assessment. Here are some common symptoms:Click to read the full article.

Backdated documentation detected during deviation investigation – evidence pack inspectors expect

Identifying indicators of backdated documentation is crucial for immediate action. Common symptoms may include:Click to read the full article.

API change not reported during inspection preparation – how to defend manufacturing readiness

Identifying early signals of potential API changes that went unreported is essential to maintaining compliance. Here are some symptoms that production staff and QC professionals should watch for:Click to read…

GDP errors in batch records during audit trail review – GDP remediation CAPA

Detecting GDP errors early is essential. Key symptoms and signals that may indicate potential documentation issues within batch records include:Click to read the full article.

PQ dossier deficiency during dossier submission – PQ assessment risk and mitigation

Recognizing initial signs of PQ dossier deficiencies is vital for timely intervention. Symptoms could manifest in various forms, including:Click to read the full article.

Incomplete contemporaneous recording during deviation investigation – inspection citation risk and mitigation

Recognizing symptoms of incomplete contemporaneous recording is the first step in mitigating risks. Key indicators include:Click to read the full article.

API change not reported during variation management – how to defend manufacturing readiness

“`html Defending Manufacturing Readiness After Unreported API Changes During Variation Management In the fast-paced world of pharmaceutical manufacturing, change management is crucial to maintaining regulatory compliance and ensuring product quality.…

Incomplete contemporaneous recording during inspection review – ALCOA+ gap analysis

Recognizing indicators of incomplete contemporaneous recording is essential for prompt action. These symptoms may present as:Click to read the full article.

PQ dossier deficiency during requalification – PQ assessment risk and mitigation

Identifying early warning signs of PQ dossier deficiencies is critical in addressing issues proactively. Symptoms can manifest in various ways, both on the production floor and within laboratory settings. Common…

Illegible entries in controlled records during inspection review – ALCOA+ gap analysis

Addressing Illegible Entries in Controlled Records for Regulatory Compliance Illegible entries in controlled records pose a significant challenge during inspection reviews, as they can undermine data integrity and compliance with…

CAPA effectiveness doubted during dossier submission – documentation gaps reviewers flag

Identifying early indicators of CAPA ineffectiveness is crucial for mitigating potential non-compliance during regulatory submissions. Some common symptoms experienced on the manufacturing floor or within laboratories include:Click to read the…

Data attribution unclear during routine operations – ALCOA+ gap analysis

Identifying symptoms and signals early is crucial in addressing data attribution issues. Operators, Quality Control (QC), Quality Assurance (QA), Engineering, and Regulatory Affairs (RA) professionals must be vigilant in looking…